1,056 hedge funds and large institutions have $36.2B invested in Biogen in 2020 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 337 increasing their positions, 437 reducing their positions, and 130 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

26% less first-time investments, than exits

New positions opened: 96 | Existing positions closed: 130

37% less call options, than puts

Call options by funds: $894M | Put options by funds: $1.43B

57% less funds holding in top 10

Funds holding in top 10: 4921 (-28)

Holders
1,056
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$894M
Puts
$1.43B
Net Calls
Net Calls Change

Top Buyers

1 +$182M
2 +$148M
3 +$142M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$114M
5
AL
AJO LP
Pennsylvania
+$91.1M
Name Holding Trade Value Shares
Change
Change in
Stake
351
$3.33M
352
$3.32M
353
$3.3M
354
$3.3M
355
$3.24M
356
$3.23M
357
$3.23M
358
$3.22M
359
$3.21M
360
$3.18M
361
$3.15M
362
$3.09M
363
$3.09M
364
$3.08M
365
$3.04M
366
$3.02M
367
$3.01M
368
$3M
369
$2.97M
370
$2.94M
371
$2.94M
372
$2.92M
373
$2.91M
374
$2.9M
375
$2.89M